Evidence map›Paper›PMID 37657957›Full record

ArticleAnais brasileiros de dermatologia

Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study.

Loren Giagio Cavalcante, Rejane Aparecida Rodrigues Domingues, Batista de Oliveira Junior, Marco Antônio Rodrigues Fernandes, Eduardo Carvalho Pessoa, Luciana Patrícia Fernandes Abbade

Open access · goldAbstract read
In one paragraph

Article in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Effectiveness of glutamine for the treatment of radiodermatitis in cancer patients: a meta-analysis of randomized controlled trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  2. Trial
  3. Topical use of chicory root extract gel on the incidence and severity of radiodermatitis in breast cancer patients: a randomized controled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  4. Review
  5. Review
  6. Article
  7. Representations of breast cancer in Brazilian lesbian/bisexual cisgender women: perspectives of patients and women without a history of the disease.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Loren Giagio CavalcanteDepartment of Nursing, Faculdade de Medicina, Universidade Estadual Paulista, Botucatu, SP, Brazil; Sector of Radiotherapy, Hospital das Clínicas de Botucatu, Botucatu, SP, Brazil.
Rejane Aparecida Rodrigues DominguesSector of Radiotherapy, Hospital das Clínicas de Botucatu, Botucatu, SP, Brazil.
Batista de Oliveira JuniorSector of Radiotherapy, Hospital das Clínicas de Botucatu, Botucatu, SP, Brazil.
Marco Antônio Rodrigues FernandesDepartment of Infectology, Dermatology, Diagnostic Imaging and Radiotherapy, Faculdade de Medicina, Universidade Estadual Paulista, Botucatu, SP, Brazil.
Eduardo Carvalho PessoaDepartment of Gynecology and Obstetrics, Faculdade de Medicina, Universidade Estadual Paulista, Botucatu, SP, Brazil.
Luciana Patrícia Fernandes AbbadeDepartment of Infectology, Dermatology, Diagnostic Imaging and Radiotherapy, Faculdade de Medicina, Universidade Estadual Paulista, Botucatu, SP, Brazil. Electronic address: fernandes.abbade@unesp.br.
Universidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the main adverse reactions of adjuvant radiotherapy for breast cancer is radiodermatitis.

objectiveTo assess the incidence of radiodermatitis in women with breast cancer, identify factors associated with its severity and determine the time at which this event occurs.

methodsProspective cohort study in 113 women with breast cancer who were evaluated before radiotherapy and at every fifth session until the end of treatment. Logistic regression and Cox proportional regression model were used for the assessment of risk factors; P values < 0.05 were considered significant.

resultsThe incidence rate of radiodermatitis was 98.2% and it was demonstrated that for each additional point of the Body Mass Index (BMI), the chance of occurrence of grades II to IV radiodermatitis increases by 14% (OR=1.14 [95% CI 1.04-1.26]; p=0.004) and statin use increases the risk of more severe skin lesions by four-fold (OR=4.27 [95% CI 1.11-16.42]; p=0.035). The exclusive use of hydrogel for skin hydration was an independent factor in delaying the onset of radiodermatitis (HR=0.55 [95% CI 0.36-0.82]; p=0.004). STUDY LIMITATIONS: The main limitation of this study was its external validity. The identified factors should be considered for services and populations similar to those in this study.

conclusionsThere was a high incidence of radiodermatitis and its severity was related to higher BMI, statin use; there was a protective effect of hydrogel use.

Indexed as

Breast NeoplasmsHydroxymethylglutaryl-CoA Reductase InhibitorsRadiodermatitisCohort StudiesFemaleHumansHydrogelsIncidenceProspective StudiesHydrogelsHydroxymethylglutaryl-CoA Reductase InhibitorsBreast neoplasmRadiodermatitisRadiotherapy, adjuvantRisk factors

Identifiers

PMID37657957
PMCPMC10964356
OpenAlexW4386286708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.